This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Two Newly Rated Stock Funds to Buy

NEW YORK ( TheStreet Ratings) -- Ratings initiated coverage of 27 stock mutual funds that accrued a sufficient track record of risk and performance data by the end of May 2011. Only two of these newly rated mutual fund earned initial grades in the 'buy' range.

Just one of the funds that opened for business in May of 2008 received our highest possible rating of A+, or Excellent. None performed better on a risk-adjusted return basis over the last three years than the Highland Long/Short Healthcare Fd A (HHCAX) rising 21.2% in a year and 12.4% annually over three years.

The fund seeks long-term capital appreciation and invests at least 80% of the value of its total assets in securities of companies principally engaged in the design, development, production, sale, management or distribution of products, services or facilitates used for or in connection with healthcare or medicine. The Highland Long/Short Healthcare Fund may also invest in preferred stocks, warrants, convertible securities, debt securities and other securities of any market capitalization issued by such companies.

Top holdings include 5.1% Genesys Ventures L.L.P. , 3.6% Caliper Life Sciences (CALP), 3.5% Keryx Biopharmaceuticals (KERX - Get Report), 3.5% CNS Response (CNS.OB), and 3.3% Cigna Corp (CI - Get Report) on the long side of the portfolio. These were balanced to reduce overall exposure to the sector with recent short positions in Becton Dickinson and Co (BDX), Athenahealth (ATHN - Get Report), Cerner Corp (CERN - Get Report), Community Health Systems (CYH - Get Report), and Mettler-Toledo International (MTD).

One drawback to the Highland Long/Short Healthcare Fund is the 5.92% net expense ratio and a 2% redemption fee should you sell your position within 60 days of purchase. Since the fund takes short positions and uses leverage there is an additional risk of loss as stocks rise in value.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ATHN $138.91 -0.64%
CERN $57.66 -0.26%
CI $139.94 0.48%
CYH $19.98 -2.35%
KERX $5.26 3.54%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs